Contract Development


Partner with SERATEC for custom Nucleic Acid-based Lateral Flow Assays (NALFAs).
These innovative assays offer superior sensitivity, specificity, and versatility compared to antibody-based systems They also enable the identification of targets where antibodies are not yet available.
At SERATEC, we combine scientific expertise with state-of-the-art technology and strict quality control to deliver rapid, reliable, and application-specific NALFA solutions.
Upgrade your diagnostics or research — collaborate with us to develop next-generation rapid detection tools.
Detailed information available in our brochure.
Have a concept or question?
Reach our R&D team directly at innovation@seratec.com
